UBE2I and ovarian cancer: As shown in Figure 5 Ubc9 siRNA significantly inhibited the migration of ES-2 ovarian cancer cells (Figure 5A), HCC1937 BRCA1 mutant TNBC cells (Figure 5 C) and CAL-51 a non-BRCA1 mutant TNBC cells (Figure 5 D).